Quanterix (QTRX) Non-Current Deffered Revenue (2017 - 2026)
Quanterix (QTRX) reported Non-Current Deffered Revenue of $2.8 million for Q1 2026, up 154.55% on a YoY basis from $1.1 million in Q1 2025, and down 52.06% quarter-over-quarter from $5.8 million in Q4 2025.
Quanterix (QTRX) Non-Current Deffered Revenue (2017 - 2026) Analysis & Trends
Quanterix has reported Non-Current Deffered Revenue for 10 years, with the latest figure at $2.8 million in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Deffered Revenue rose 154.55% year-over-year to $2.8 million; the trailing twelve-month figure through Mar 2026 stood at $2.8 million (up 154.55% YoY), and the FY2025 full-year result was $5.8 million, up 443.34% from the prior year.
- Non-Current Deffered Revenue for Q1 2026 stood at $2.8 million, down from $5.8 million in the prior quarter.
- The five-year high for Non-Current Deffered Revenue was $7.3 million in Q3 2025, with the low at $884000.0 in Q3 2024.
- Historically, Non-Current Deffered Revenue has averaged $1.9 million across 5 years, with a median of $1.2 million in 2023.
- Annual changes were most pronounced in 2024 — Non-Current Deffered Revenue slumped 34.25% — and 2025, when it jumped 730.43%.
- Quanterix's Non-Current Deffered Revenue stood at $1.4 million in 2022, then dropped by 13.29% to $1.2 million in 2023, then decreased by 12.55% to $1.1 million in 2024, then surged by 443.34% to $5.8 million in 2025, then plunged by 52.06% to $2.8 million in 2026.
- The last three Non-Current Deffered Revenue figures came in at $2.8 million (Q1 2026), $5.8 million (Q4 2025), and $7.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 512.79 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Quanterix | 159.26 Mn | 59.99 Mn | 15.57 Mn | 2.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.80 Mn |
| Dec 31, 2025 | 5.83 Mn |
| Sep 30, 2025 | 7.34 Mn |
| Jun 30, 2025 | 1.06 Mn |
| Mar 31, 2025 | 1.10 Mn |
| Dec 31, 2024 | 1.07 Mn |
| Sep 30, 2024 | 884,000.00 |
| Jun 30, 2024 | 928,000.00 |
| Mar 31, 2024 | 933,000.00 |
| Dec 31, 2023 | 1.23 Mn |
| Sep 30, 2023 | 1.13 Mn |
| Jun 30, 2023 | 1.30 Mn |
| Mar 31, 2023 | 1.42 Mn |
| Dec 31, 2022 | 1.42 Mn |
| Sep 30, 2022 | 1.59 Mn |
| Jun 30, 2022 | 1.53 Mn |
| Mar 31, 2022 | 1.22 Mn |
| Dec 31, 2021 | 1.10 Mn |
| Sep 30, 2021 | 929,000.00 |
| Jun 30, 2021 | 740,000.00 |